Atomic Storytelling From the People Who Know

Experts from the world of nuclear threats and international security shared their amusing, poignant and personal accounts from key moments in their professional lives during a virtual storytelling event, “The Countdown: Atomic Storytelling From the People Who Know.”

Scientists, policy analysts and activists all presented five-minute stories of their experiences working for national security in the U.S. and in critical global hotspots. Their stories were honed with help from TV/film writers from Madam Secretary, Designated Survivor, Crazy Rich Asians and others.

Mental Health Stigma

Suicide is the tenth leading cause of death for all Americans (and the second leading cause of death for those between 15 and 34). People struggle with the symptoms and disabilities, and are challenged by the stigma that results from misconceptions about mental illness.

Diversity in Clinical Trials

The medications, therapies, and treatments that we use to deal with different illnesses and injuries have been studied using clinical trials. According to the U.S. Food and Drug Administration (FDA), African Americans represent 12% of the U.S. population but only 5% of clinical trial participants and Hispanics/Latinos make up 16% of the population but only 1% of clinical trial participants.

Clinical Trials_Cardiovascular Health

When a variety of racial/ethnic groups are represented in clinical trials, valuable information about certain diseases, treatments, and medications are revealed. This information helps to improve how we treat and prevent illnesses in different communities. Cardiovascular (heart) disease is one particular illness where we see major differences among different groups of people.